NONLINEAR ASSESSMENT OF PHENYTOIN BIOAVAILABILITY

被引：102

作者：

JUSKO, WJ

KOUP, JR

ALVAN, G

机构：

[1] SUNY BUFFALO,SCH PHARM,DEPT PHARM,BUFFALO,NY 14214

[2] HUDDINGE UNIV HOSP,DEPT CLIN PHARMACOL,HUDDINGE,SWEDEN

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1976年 / 4卷 / 04期

关键词：

D O I：

10.1007/BF01063122

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：327 / 336

页数：10

共 12 条

[1]

ALBERT KS, 1974, CLIN PHARMACOL THER, V16, P727

[2]

GARRETTSON LK, 1975, CLIN PHARMACOL THER, V17, P481

[3]

GERBER N, 1972, RES COMMUN CHEM PATH, V3, P455

[4]

GLAZKO AJ, 1972, ANTIEPILEPTIC DRUGS, P127

[5]

GUGLER R, 1976, CLIN PHARMACOL THER, V19, P135

[6]

KOSTENBAUDER HB, 1975, CLIN PHARMACOL THER, V18, P449

[7] BIOAVAILABILITY, CLINICAL EFFECTIVENESS, AND PUBLIC INTEREST [J].

LEVY, G .

PHARMACOLOGY, 1972, 8 (1-3) :33-43

[8] PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF PHENYTOIN IN MAN [J].

LUND, L ;

ALVAN, G ;

BERLIN, A ;

ALEXANDERSON, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (02) :81-86

[9] BIOAVAILABILITY CALCULATIONS FOR DRUGS SHOWING SIMULTANEOUS FIRST-ORDER AND CAPACITY-LIMITED ELIMINATION KINETICS [J].

MARTIS, L ;

LEVY, RH .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (04) :283-294

[10] PHENYTOIN DOSE ADJUSTMENT IN EPILEPTIC PATIENTS [J].

MAWER, GE ;

MULLEN, PW ;

RODGERS, M ;

ROBINS, AJ ;

LUCAS, SB .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (02) :163-168

← 1 2 →